Doctors support malpractice provision in SGR bill

A little-noticed provision in legislation to repeal the Medicare Sustainable Growth Rate formula would protect doctors from lawsuits based on their performance on federal quality measures. Language contained in H.R. 2, the
Source: Skin and Allergy News - Category: Dermatology Tags: CARD Practice Economics CHEST Practice Economics CEN Practice Economics CNN Practice Economics CPN Practice Economics EM Practice Economics FPN Practice Economics HOSP Practice Economics IMN Practice Economics OBGYN Practice Economics Source Type: news

Related Links:

does everyone have emergency airway/equipment/meds for in clinic procedure room? i only do simple joint/nerve and some lumbar injections. rest goes to ASC. i did have one episode of contrast allergy last year which made me think i should at least have epi pen in clinic.. what are people doing and what kits/meds do you have?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pain Medicine Source Type: forums
PMID: 32479163 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - Category: ENT & OMF Authors: Tags: Am J Rhinol Allergy Source Type: research
AbstractNew recommendations from the Global Initiative for Asthma (GINA) were released in a pocket guide form on April 12, 2019. These recommendations provide very important changes to the management of asthma, especially regarding the treatment of intermittent and mild asthma. Due to safety concerns, GINA experts no longer recommend treatment with a short-acting β2 agonist alone. Henceforth, all adults and adolescents (but not yet children) with mild asthma should receive either symptom-driven or daily low-dose ICS. The main goal of this new approach is to reduce the risk of serious asthma exacerbations and asthma-re...
Source: Clinical and Translational Allergy - Category: Allergy & Immunology Source Type: research
Electrochemical detection of β-lactoglobulin based on a highly selective DNA aptamer and flower-like Au@BiVO4 microspheres. Anal Chim Acta. 2020 Jul 11;1120:1-10 Authors: Xu S, Dai B, Zhao W, Jiang L, Huang H Abstract Beta-lactoglobulin is a natural milk protein and the main cause of infant milk allergy. In this work, a sensitive, selective and inexpensive electrochemical biosensor for the detection of β-lactoglobulin was developed. In this sensor, a DNA aptamer was used instead of an expensive antibody as the recognition group highly selective for β-lactoglobulin. The flower-like BiVO4...
Source: Analytica Chimica Acta - Category: Chemistry Authors: Tags: Anal Chim Acta Source Type: research
(CNN) — A five-day course of the antiviral drug remdesivir sped recovery in moderately ill patients with pneumonia from Covid-19, drugmaker Gilead Sciences announced in a statement Monday. It’s more evidence that the drug can help patients, however outside experts are not calling this a “game changer” quite yet. Coronavirus patients who were hospitalized, but not sick enough to need oxygen from a ventilator, were more likely to recover after a five-day course of remdesivir than those given the current standard of care alone, Gilead said. The results from the Phase III clinical trial on the drug have...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health CNN Coronavirus remdesivir Source Type: news
TUESDAY, June 2, 2020 -- Food allergies may be under-diagnosed among children covered by Medicaid, a new study suggests. " We were surprised to find such a large discrepancy in estimates of food allergy prevalence in children on Medicaid compared to...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Mast cells are present in mucosal and connective tissues throughout the body. They participate in the innate and adaptive immune process and have an important role in inflammation and allergy. Mast cells located in the submucosa of the respiratory tract are known to be activated by the SARS-CoV-2 virus.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
Condition:   Diabetic Macular Edema Interventions:   Drug: Dexamethasone implant;   Drug: Aflibercept Sponsors:   The Cleveland Clinic;   Allergan Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   COVID-19 Intervention:   Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Diabetic Macular Edema Interventions:   Drug: Dexamethasone implant;   Drug: Aflibercept Sponsors:   The Cleveland Clinic;   Allergan Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Dermatology | Economics | Lawsuits | Legislation | Malpractice | Medicare | OBGYN | Skin